Showing results (1811-1820 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytesS Ikemoto, S Wada, M Kamizuru, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancerE C De Boer, W H De Jong, P A Steerenberg, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxinsJ T Safrit, B Bonavida
Cancer Immunology, Immunotherapy : CII|June 29, 2004
Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cellsMarina Bacac, Marta Vadori, Gianni Sava, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signalsMohamed Kharfan-Dabaja, Ernesto Ayala, Inna Lindner, et al.
Cancer Immunology, Immunotherapy : CII|June 19, 2004
Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancerUri Galili
Cancer Immunology, Immunotherapy : CII|June 9, 2004
Dendritic cell-tumor cell hybrid vaccination for metastatic cancerJose Alexandre M Barbuto, Luis F C Ensina, Andreia R Neves, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2004
Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2Christian Kersten, Jan Delabie, Gustav Gaudernack, et al.
Cancer Immunology, Immunotherapy : CII|July 13, 2004
Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signalsElissaveta Naumova, Anastassia Mihaylova, Konstantin Stoitchkov, et al.
Cancer Immunology, Immunotherapy : CII|May 25, 2004
Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunityRonald C Kennedy, Michael H Shearer, Devin B Lowe, et al.
Pageof 652